Multi-country collaboration in responding to global infectious disease threats: lessons for Europe from the COVID-19 pandemic - The Lancet Regional Health – Europe
GHIT Fund RFP 2013-002
Hit and lead criteria in drug discovery for infectious diseases of the developing world | Nature Reviews Drug Discovery
The Global Health Innovative Technology Fund provides grant to Mitsubishi Tanabe Pharma and DNDi for Chagas disease and leishman
GHIT Fund secures $20 million pledge from Wellcome | Philanthropy news | PND
Interest spikes for infectious disease careers amid pandemic - Northwestern Now
GHIT Fund Brochure — BI BOOP
The coronavirus pandemic and US federal investment in science
Joint research identifies hit compounds for the development of a new treatment for malaria Mitsubishi Tanabe Pharma uses its com
Research-based pharmaceutical industry 360-degree efforts to fight Neglected Tropical Diseases (NTDs) 2013 - IFPMA
Investment Opportunities | Global Health Innovative Technology Fund
GHIT Fund Archives - Asian Scientist Magazine
Malaria Research—What Next? | Science
Global Infectious Diseases Institute
Why Global Health R&D | Global Health Innovative Technology Fund
GHIT Fund secures $20 million pledge from Wellcome | Philanthropy news | PND
Infectious Diseases, Conflict, and Humanitarian Crises | Center for Global Health Science and Security | Georgetown University
News Detail | Global Health Innovative Technology Fund
Japanese GHIT Fund to include diagnostics and drugs for leishmaniasis
GHIT Fund Announces New Investments: A Total of 790 Million Yen for Product Development of Neglected Tropical Diseases
EISAI CO-ESTABLISHES THE GLOBAL HEALTH INNOVATIVE TECHNOLOGY FUND
From a Phase 2 TB Vaccine Trial, to Early Work to Neutralize Drug-Resistant Malaria, $10.7 Million in New Investments from GHIT
Overlooked and underfunded: neglected diseases exert a toll
Flood-hit Pakistan faces spread of infectious diseases
Estimating the cost of vaccine development against epidemic infectious diseases: a cost minimisation study - The Lancet Global Health
